Effects of amperozide, 8-OH-DPAT, and FG 5974 on operant responding for ethanol

被引:35
作者
Roberts, AJ
McArthur, RA
Hull, EE
Post, C
Koob, GF
机构
[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
[2] Pharmacia & Upjohn SpA, I-20014 Nerviano, MI, Italy
关键词
alcohol; ethanol; saccharin; self-administration; serotonin; 5-HT1A receptor; 5-HT2A receptor; rat;
D O I
10.1007/s002130050589
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Both 5-HT1A and 5-HT2A receptors have been implicated in modulating ethanol self-administration. A novel serotonergic compound, FG 5974, with combined 5-HT1A agonist/5-HT2A antagonist activities, has shown effects in decreasing ethanol consumption in two-bottle choice paradigms. In the present study, the effect of this compound on operant responding for ethanol (as well as water and a saccharin solution) was compared to compounds possessing the separate neuropharmacological effects of this drug (the 5-HT1A agonist. 8-OH-DPAT, and the 5-HT2A antagonist, amperozide). While all three serotonergic compounds decreased operant responding for ethanol, only FG 5974 had no effect on water and saccharin responding. These results suggest that combined 5HT(1A) agonist/5-HT2A antagonist activity provides a more selective effect on ethanol reinforcement than either neuropharmacological action alone. Therefore, further analysis of mixed serotonergic compounds in general, and FG 5974 in particular, is warranted as they offer potential treatments for alcoholism.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 38 条
[1]   PRECLINICAL PHARMACOLOGY OF FG5893 - A POTENTIAL ANXIOLYTIC DRUG WITH HIGH-AFFINITY FOR BOTH 5-HT1A AND 5-HT2A RECEPTORS [J].
ALBINSSON, A ;
BJORK, A ;
SVARTENGREN, J ;
KLINT, T ;
ANDERSSON, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 261 (03) :285-294
[2]   EFFECTS OF AMPEROZIDE IN SCHIZOPHRENIA - AN OPEN STUDY OF A POTENT 5-HT2 RECEPTOR ANTAGONIST [J].
AXELSSON, R ;
NILSSON, A ;
CHRISTENSSON, E ;
BJORK, A .
PSYCHOPHARMACOLOGY, 1991, 104 (03) :287-292
[3]   5-HT RECEPTORS AS TARGETS FOR THE DEVELOPMENT OF NOVEL ANXIOLYTIC DRUGS - MODELS, MECHANISMS AND FUTURE-DIRECTIONS [J].
BARRETT, JE ;
VANOVER, KE .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :1-12
[4]   BUSPIRONE IN THE TREATMENT OF ALCOHOLIC PATIENTS [J].
BRUNO, F .
PSYCHOPATHOLOGY, 1989, 22 :49-59
[5]   AMPEROZIDE - A NEW PHARMACOLOGICAL APPROACH IN THE TREATMENT OF SCHIZOPHRENIA [J].
CHRISTENSSON, E ;
BJORK, A .
PHARMACOLOGY & TOXICOLOGY, 1990, 66 :5-7
[6]   DO FUNCTIONAL-RELATIONSHIPS EXIST BETWEEN 5-HT1A AND 5-HT2 RECEPTORS [J].
DARMANI, NA ;
MARTIN, BR ;
PANDEY, U ;
GLENNON, RA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (04) :901-906
[7]  
DEVRY J, 1995, PSYCHOPHARMACOLOGY, V121, P1
[8]   VOLUNTARY ETHANOL-CONSUMPTION IN RATS - AN EXAMINATION OF BLOOD-BRAIN ETHANOL LEVELS AND BEHAVIOR [J].
GILL, K ;
FRANCE, C ;
AMIT, Z .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1986, 10 (04) :457-462
[9]   BEHAVIORAL ECONOMICS [J].
HURSH, SR .
JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR, 1984, 42 (03) :435-452
[10]  
Kleven MS, 1996, J PHARMACOL EXP THER, V276, P388